These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 18951449)

  • 1. Assessment of functional effects of unclassified genetic variants.
    Couch FJ; Rasmussen LJ; Hofstra R; Monteiro AN; Greenblatt MS; de Wind N;
    Hum Mutat; 2008 Nov; 29(11):1314-26. PubMed ID: 18951449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing pathogenicity: overview of results from the IARC Unclassified Genetic Variants Working Group.
    Tavtigian SV; Greenblatt MS; Goldgar DE; Boffetta P;
    Hum Mutat; 2008 Nov; 29(11):1261-4. PubMed ID: 18951436
    [No Abstract]   [Full Text] [Related]  

  • 3. Functional Repair Assay for the Diagnosis of Constitutional Mismatch Repair Deficiency From Non-Neoplastic Tissue.
    Shuen AY; Lanni S; Panigrahi GB; Edwards M; Yu L; Campbell BB; Mandel A; Zhang C; Zhukova N; Alharbi M; Bernstein M; Bowers DC; Carroll S; Cole KA; Constantini S; Crooks B; Dvir R; Farah R; Hijiya N; George B; Laetsch TW; Larouche V; Lindhorst S; Luiten RC; Magimairajan V; Mason G; Mason W; Mordechai O; Mushtaq N; Nicholas G; Oren M; Palma L; Pedroza LA; Ramdas J; Samuel D; Wolfe Schneider K; Seeley A; Semotiuk K; Shamvil A; Sumerauer D; Toledano H; Tomboc P; Wierman M; Van Damme A; Lee YY; Zapotocky M; Bouffet E; Durno C; Aronson M; Gallinger S; Foulkes WD; Malkin D; Tabori U; Pearson CE
    J Clin Oncol; 2019 Feb; 37(6):461-470. PubMed ID: 30608896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of Constitutional Mismatch Repair-Deficiency Syndrome Based on Microsatellite Instability and Lymphocyte Tolerance to Methylating Agents.
    Bodo S; Colas C; Buhard O; Collura A; Tinat J; Lavoine N; Guilloux A; Chalastanis A; Lafitte P; Coulet F; Buisine MP; Ilencikova D; Ruiz-Ponte C; Kinzel M; Grandjouan S; Brems H; Lejeune S; Blanché H; Wang Q; Caron O; Cabaret O; Svrcek M; Vidaud D; Parfait B; Verloes A; Knappe UJ; Soubrier F; Mortemousque I; Leis A; Auclair-Perrossier J; Frébourg T; Fléjou JF; Entz-Werle N; Leclerc J; Malka D; Cohen-Haguenauer O; Goldberg Y; Gerdes AM; Fedhila F; Mathieu-Dramard M; Hamelin R; Wafaa B; Gauthier-Villars M; Bourdeaut F; Sheridan E; Vasen H; Brugières L; Wimmer K; Muleris M; Duval A;
    Gastroenterology; 2015 Oct; 149(4):1017-29.e3. PubMed ID: 26116798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opportunistic testing of BRCA1, BRCA2 and mismatch repair genes improves the yield of phenotype driven hereditary cancer gene panels.
    Feliubadaló L; López-Fernández A; Pineda M; Díez O; Del Valle J; Gutiérrez-Enríquez S; Teulé A; González S; Stjepanovic N; Salinas M; Capellá G; Brunet J; Lázaro C; Balmaña J;
    Int J Cancer; 2019 Nov; 145(10):2682-2691. PubMed ID: 30927264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Locus-specific databases and recommendations to strengthen their contribution to the classification of variants in cancer susceptibility genes.
    Greenblatt MS; Brody LC; Foulkes WD; Genuardi M; Hofstra RM; Olivier M; Plon SE; Sijmons RH; Sinilnikova O; Spurdle AB;
    Hum Mutat; 2008 Nov; 29(11):1273-81. PubMed ID: 18951438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification of genetic variants in genes associated with Lynch syndrome using a clinical history weighting algorithm.
    Morris B; Hughes E; Rosenthal E; Gutin A; Bowles KR
    BMC Genet; 2016 Jul; 17(1):99. PubMed ID: 27363726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results.
    Plon SE; Eccles DM; Easton D; Foulkes WD; Genuardi M; Greenblatt MS; Hogervorst FB; Hoogerbrugge N; Spurdle AB; Tavtigian SV;
    Hum Mutat; 2008 Nov; 29(11):1282-91. PubMed ID: 18951446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico analysis of missense substitutions using sequence-alignment based methods.
    Tavtigian SV; Greenblatt MS; Lesueur F; Byrnes GB;
    Hum Mutat; 2008 Nov; 29(11):1327-36. PubMed ID: 18951440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of cosegregation analysis methods for the clinical setting.
    Rañola JMO; Liu Q; Rosenthal EA; Shirts BH
    Fam Cancer; 2018 Apr; 17(2):295-302. PubMed ID: 28695303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classification of MSH6 Variants of Uncertain Significance Using Functional Assays.
    Frederiksen JH; Jensen SB; Tümer Z; Hansen TVO
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive functional assay-based classification of PMS2 variants in Lynch syndrome.
    Rayner E; Tiersma Y; Fortuno C; van Hees-Stuivenberg S; Drost M; Thompson B; Spurdle AB; de Wind N
    Hum Mutat; 2022 Sep; 43(9):1249-1258. PubMed ID: 35451539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic testing and prevention of hereditary cancer at the MMCI--over 10 years of experience.
    Foretova L; Petrakova K; Palacova M; Kalabova R; Svoboda M; Navratilova M; Schneiderova M; Bolcak K; Krejci E; Drazan L; Mikova M; Hazova J; Vasickova P; Machackova E
    Klin Onkol; 2010; 23(6):388-400. PubMed ID: 21348412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hereditary cancer syndromes.
    Fostira F; Thodi G; Konstantopoulou I; Sandaltzopoulos R; Yannoukakos D
    J BUON; 2007 Sep; 12 Suppl 1():S13-22. PubMed ID: 17935271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A database to support the interpretation of human mismatch repair gene variants.
    Ou J; Niessen RC; Vonk J; Westers H; Hofstra RM; Sijmons RH
    Hum Mutat; 2008 Nov; 29(11):1337-41. PubMed ID: 18951442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exceptions to the rule: case studies in the prediction of pathogenicity for genetic variants in hereditary cancer genes.
    Rosenthal ET; Bowles KR; Pruss D; van Kan A; Vail PJ; McElroy H; Wenstrup RJ
    Clin Genet; 2015 Dec; 88(6):533-41. PubMed ID: 25639900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Systematic Comparison of Traditional and Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Genes in More Than 1000 Patients.
    Lincoln SE; Kobayashi Y; Anderson MJ; Yang S; Desmond AJ; Mills MA; Nilsen GB; Jacobs KB; Monzon FA; Kurian AW; Ford JM; Ellisen LW
    J Mol Diagn; 2015 Sep; 17(5):533-44. PubMed ID: 26207792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic evidence and integration of various data sources for classifying uncertain variants into a single model.
    Goldgar DE; Easton DF; Byrnes GB; Spurdle AB; Iversen ES; Greenblatt MS;
    Hum Mutat; 2008 Nov; 29(11):1265-72. PubMed ID: 18951437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Validation of a 34-Gene Inherited Cancer Predisposition Panel Using Next-Generation Sequencing.
    Rosenthal SH; Sun W; Zhang K; Liu Y; Nguyen Q; Gerasimova A; Nery C; Cheng L; Castonguay C; Hiller E; Li J; Elzinga C; Wolfson D; Smolgovsky A; Chen R; Buller-Burckle A; Catanese J; Grupe A; Lacbawan F; Owen R
    Biomed Res Int; 2020; 2020():3289023. PubMed ID: 32090079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk.
    Judkins T; Leclair B; Bowles K; Gutin N; Trost J; McCulloch J; Bhatnagar S; Murray A; Craft J; Wardell B; Bastian M; Mitchell J; Chen J; Tran T; Williams D; Potter J; Jammulapati S; Perry M; Morris B; Roa B; Timms K
    BMC Cancer; 2015 Apr; 15():215. PubMed ID: 25886519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.